{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T01:11:49Z","timestamp":1705540309667},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Drug repositioning refers to the identification of new indications for existing drugs. Drug-based inference methods for drug repositioning apply some unique features of drugs for new indication prediction. Complementary information is provided by these different features. It is therefore necessary to integrate these features for more accurate in silico drug repositioning.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we collect 3 different types of drug features (i.e., chemical, genomic and pharmacological spaces) from public databases. Similarities between drugs are separately calculated based on each of the features. We further develop a fusion method to combine the 3 similarity measurements. We test the inference abilities of the 4 similarity datasets in drug repositioning under the guilt-by-association principle. Leave-one-out cross-validations show the integrated similarity measurement <jats:italic>IntegratedSim<\/jats:italic> receives the best prediction performance, with the highest AUC value of 0.8451 and the highest AUPR value of 0.2201. Case studies demonstrate <jats:italic>IntegratedSim<\/jats:italic> produces the largest numbers of confirmed predictions in most cases. Moreover, we compare our integration method with 3 other similarity-fusion methods using the datasets in our study. Cross-validation results suggest our method improves the prediction accuracy in terms of AUC and AUPR values.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study suggests that the 3 drug features used in our manuscript are valuable information for drug repositioning. The comparative results indicate that integration of the 3 drug features would improve drug-disease association prediction. Our study provides a strategy for the fusion of different drug features for in silico drug repositioning.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-021-03988-x","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:39:42Z","timestamp":1612823982000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces"],"prefix":"10.1186","volume":"22","author":[{"given":"Hailin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingpu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"issue":"9","key":"3988_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","volume":"323","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009\u20132018. JAMA. 2020;323(9):844\u201353.","journal-title":"JAMA"},{"issue":"3","key":"3988_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL. How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge. Nat Rev Drug DISCOV. 2010;9(3):203\u201314.","journal-title":"Nat Rev Drug DISCOV"},{"issue":"8","key":"3988_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3(8):673\u201383.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3988_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, et al. Drug repurposing: progress, challenges and recommendations. Nat REV Drug Discov. 2019;18(1):41\u201358.","journal-title":"Nat REV Drug Discov"},{"key":"3988_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","volume":"38","author":"C Harrison","year":"2020","unstructured":"Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotechnol. 2020;38:379\u201381.","journal-title":"Nat Biotechnol"},{"issue":"5795","key":"3988_CR6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet J, Subramanian A, Ross KN, et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929\u201335.","journal-title":"Science"},{"issue":"7270","key":"3988_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"MJ Keiser","year":"2009","unstructured":"Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, et al. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175\u201381.","journal-title":"Nature"},{"issue":"12","key":"3988_CR8","doi-asserted-by":"publisher","first-page":"e28025","DOI":"10.1371\/journal.pone.0028025","volume":"6","author":"L Yang","year":"2011","unstructured":"Yang L, Agarwal P. Systematic drug repositioning based on clinical side-effects. PLoS ONE. 2011;6(12):e28025.","journal-title":"PLoS ONE"},{"issue":"7","key":"3988_CR9","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1039\/C6MB00182C","volume":"12","author":"V Rajendran","year":"2016","unstructured":"Rajendran V. Structural analysis of oncogenic mutation of isocitrate dehydrogenase 1. Mol Biosyst. 2016;12(7):2276\u201387.","journal-title":"Mol Biosyst"},{"key":"3988_CR10","first-page":"e2478","volume":"4","author":"C Huang","year":"2016","unstructured":"Huang C, Ciou J, Chen S, Kok VC, Chung Y, Tsai JJP, Kurubanjerdjit N, Huang CF, Ng K. Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells. PeerJ (San Francisco, CA). 2016;4:e2478.","journal-title":"PeerJ (San Francisco, CA)"},{"issue":"1","key":"3988_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/jcb.26257","volume":"119","author":"V Rajendran","year":"2017","unstructured":"Rajendran V, Gopalakrishnan C, Sethumadhavan R. Pathological role of a point mutation (T315I) in BCR-ABL1 protein-A computational insight. J Cell Biochem. 2017;119(1):918\u201325.","journal-title":"J Cell Biochem"},{"key":"3988_CR12","doi-asserted-by":"crossref","unstructured":"Chtita S, Belhassan A, Aouidate A, Belaidi S, Bouachrine M, Lakhlifi T. Discovery of potent SARS-CoV-2 inhibitors from approved antiviral drugs via docking and virtual screening. Comb Chem High Throughput Screen. 2020;23:1.","DOI":"10.2174\/1386207323999200730205447"},{"key":"3988_CR13","doi-asserted-by":"publisher","first-page":"104117","DOI":"10.1016\/j.compbiomed.2020.104117","volume":"128","author":"VK Bhardwaj","year":"2021","unstructured":"Bhardwaj VK, Singh R, Das P, Purohit R. Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs. Comput Biol Med. 2021;128:104117.","journal-title":"Comput Biol Med"},{"issue":"1","key":"3988_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/bfgp\/elx015","volume":"17","author":"KD Rutherford","year":"2018","unstructured":"Rutherford KD, Mazandu GK, Mulder NJ. A systems-level analysis of drug\u2013target\u2013disease associations for drug repositioning. Brief Funct Genomics. 2018;17(1):34\u201341.","journal-title":"Brief Funct Genomics"},{"key":"3988_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ygeno.2020.10.001","volume":"113","author":"R Singh","year":"2020","unstructured":"Singh R, Bhardwaj VK, Sharma J, Das P, Purohit R. Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants. Genomics. 2020;113:707\u201315.","journal-title":"Genomics."},{"issue":"5","key":"3988_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.1837","volume":"29","author":"P Wicks","year":"2011","unstructured":"Wicks P, Vaughan TE, Massagli MP, Heywood J. Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nat Biotechnol. 2011;29(5):411\u20134.","journal-title":"Nat Biotechnol"},{"issue":"17","key":"3988_CR17","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1080\/07391102.2019.1696709","volume":"38","author":"R Singh","year":"2020","unstructured":"Singh R, Bhardwaj V, Das P, Purohit R. Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: a computational perspective. J Biomol Struct Dyn. 2020;38(17):5126\u201335.","journal-title":"J Biomol Struct Dyn"},{"key":"3988_CR18","doi-asserted-by":"crossref","unstructured":"Paik H, Chung A, Park H, Park RW, Suk K, Kim J, Kim H, Lee K, Butte AJ. Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records. Sci Rep UK. 2015;5(1):8580.","DOI":"10.1038\/srep08580"},{"key":"3988_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ijbiomac.2020.01.212","volume":"148","author":"VK Bhardwaj","year":"2020","unstructured":"Bhardwaj VK, Purohit R. A new insight into protein\u2013protein interactions and the effect of conformational alterations in PCNA. Int J Biol Macromol. 2020;148:999\u20131009.","journal-title":"Int J Biol Macromol"},{"key":"3988_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.plaphy.2020.05.005","volume":"154","author":"R Singh","year":"2020","unstructured":"Singh R, Bhardwaj VK, Sharma J, Purohit R. Identification of novel and selective agonists for ABA receptor PYL3. Plant Physiol Biochem. 2020;154:387\u201395.","journal-title":"Plant Physiol Biochem"},{"key":"3988_CR21","doi-asserted-by":"publisher","unstructured":"Bhardwaj VK, Purohit R. Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation. J Biomol Struct Dyn. 2020. https:\/\/doi.org\/10.1080\/07391102.2020.1772109.","DOI":"10.1080\/07391102.2020.1772109"},{"key":"3988_CR22","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/nbt.2758","volume":"31","author":"Z Wang","year":"2013","unstructured":"Wang Z, Zhang H. Rational drug repositioning by medical genetics. Nat Biotechnol. 2013;31:1080\u20132.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"3988_CR23","doi-asserted-by":"publisher","first-page":"e62975","DOI":"10.1371\/journal.pone.0062975","volume":"8","author":"H Chen","year":"2013","unstructured":"Chen H, Zhang Z. A semi-supervised method for drug\u2013target interaction prediction with consistency in networks. PLoS ONE. 2013;8(5):e62975.","journal-title":"PLoS ONE"},{"key":"3988_CR24","doi-asserted-by":"publisher","first-page":"105494","DOI":"10.1016\/j.cmpb.2020.105494","volume":"194","author":"V KumarBhardwaj","year":"2020","unstructured":"KumarBhardwaj V, Singh R, Sharma J, Das P, Purohit R. Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation-regulated kinase. Comput Methods Programs Biomed. 2020;194:105494.","journal-title":"Comput Methods Programs Biomed"},{"issue":"15","key":"3988_CR25","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1021\/jm300576q","volume":"55","author":"S Dakshanamurthy","year":"2012","unstructured":"Dakshanamurthy S, Issa NT, Assefnia S, Seshasayee A, Peters OJ, Madhavan S, Uren A, Brown ML, Byers SW. Predicting new indications for approved drugs using a proteochemometric method. J Med Chem. 2012;55(15):6832\u201348.","journal-title":"J Med Chem"},{"key":"3988_CR26","doi-asserted-by":"publisher","unstructured":"Bhardwaj VK, Singh R, Sharma J, Rajendran V, Purohit R, Kumar S. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. 2020.\nhttps:\/\/doi.org\/10.1080\/07391102.2020.1766572","DOI":"10.1080\/07391102.2020.1766572"},{"key":"3988_CR27","doi-asserted-by":"publisher","unstructured":"Nandi S, Kumar M, Saxena M, Saxena AK. The antiviral and antimalarial drug repurposing in quest of chemotherapeutics to combat COVID-19 utilizing structure-based molecular docking. Comb Chem High Throughput Screen. 2020. https:\/\/doi.org\/10.2174\/1386207323999200824115536.","DOI":"10.2174\/1386207323999200824115536"},{"issue":"4","key":"3988_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/bib\/bbr013","volume":"12","author":"JT Dudley","year":"2011","unstructured":"Dudley JT, Deshpande T, Butte AJ. Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform. 2011;12(4):303\u201311.","journal-title":"Brief Bioinform"},{"key":"3988_CR29","doi-asserted-by":"crossref","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ. Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res. 2021;49:D1138\u2013D1143.","DOI":"10.1093\/nar\/gkaa891"},{"issue":"1","key":"3988_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1758-2946-5-30","volume":"5","author":"F Napolitano","year":"2013","unstructured":"Napolitano F, Zhao Y, Moreira VM, Tagliaferri R, Kere J, D\u2019Amato M, Greco D. Drug repositioning: a machine-learning approach through data integration. J Cheminform. 2013;5(1):30.","journal-title":"J Cheminform"},{"issue":"7","key":"3988_CR31","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/bioinformatics\/bty754","volume":"35","author":"E Oerton","year":"2019","unstructured":"Oerton E, Roberts I, Lewis PSH, Guilliams T, Bender A. Understanding and predicting disease relationships through similarity fusion. Bioinformatics. 2019;35(7):1213\u201320.","journal-title":"Bioinformatics"},{"key":"3988_CR32","doi-asserted-by":"crossref","unstructured":"Li J, Zhao Y, Zhou S, Zhou Y, Lang L. Inferring lncRNA functional similarity based on integrating heterogeneous network data. Front Bioeng Biotechnol. 2020;8:27.","DOI":"10.3389\/fbioe.2020.00027"},{"issue":"11","key":"3988_CR33","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12(11):847\u201365.","journal-title":"Nat Rev Drug Discov"},{"issue":"S2","key":"3988_CR34","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1755-8794-8-S2-S2","volume":"8","author":"L Yu","year":"2015","unstructured":"Yu L, Huang J, Ma Z, Zhang J, Zou Y, Gao L. Inferring drug-disease associations based on known protein complexes. BMC Med Genomics. 2015;8(S2):S2.","journal-title":"BMC Med Genomics"},{"key":"3988_CR35","first-page":"1","volume":"2015","author":"H Chen","year":"2015","unstructured":"Chen H, Zhang Z. A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning. Biomed Res Int. 2015;2015:1\u20139.","journal-title":"Biomed Res Int"},{"key":"3988_CR36","doi-asserted-by":"crossref","unstructured":"Wang Z, Monteiro CD, Jagodnik KM, Fernandez NF, Gundersen GW, Rouillard AD, Jenkins SL, Feldmann AS, Hu KS, McDermott MG, et al. Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd. Nat Commun. 2016;7(1):12846.","DOI":"10.1038\/ncomms12846"},{"issue":"24","key":"3988_CR37","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1093\/bioinformatics\/btz418","volume":"35","author":"X Zeng","year":"2019","unstructured":"Zeng X, Zhu S, Liu X, Zhou Y, Nussinov R, Cheng F. deepDR: a network-based deep learning approach to in silico drug repositioning. Bioinformatics. 2019;35(24):5191\u20138.","journal-title":"Bioinformatics"},{"issue":"11","key":"3988_CR38","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/bioinformatics\/bty013","volume":"34","author":"H Luo","year":"2018","unstructured":"Luo H, Li M, Wang S, Liu Q, Li Y, Wang J. Computational drug repositioning using low-rank matrix approximation and randomized algorithms. Bioinformatics. 2018;34(11):1904\u201312.","journal-title":"Bioinformatics"},{"key":"3988_CR39","doi-asserted-by":"crossref","unstructured":"Zhang W, Yue X, Lin W, Wu W, Liu R, Huang F, Liu F. Predicting drug-disease associations by using similarity constrained matrix factorization. BMC Bioinform. 2018;19(1):233.","DOI":"10.1186\/s12859-018-2220-4"},{"issue":"14","key":"3988_CR40","doi-asserted-by":"publisher","first-page":"i455","DOI":"10.1093\/bioinformatics\/btz331","volume":"35","author":"M Yang","year":"2019","unstructured":"Yang M, Luo H, Li Y, Wang J. Drug repositioning based on bounded nuclear norm regularization. Bioinformatics. 2019;35(14):i455\u201363.","journal-title":"Bioinformatics"},{"issue":"7","key":"3988_CR41","doi-asserted-by":"publisher","first-page":"e1008040","DOI":"10.1371\/journal.pcbi.1008040","volume":"16","author":"H Chen","year":"2020","unstructured":"Chen H, Cheng F, Li J. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding. PLoS Comput Biol. 2020;16(7):e1008040.","journal-title":"PLoS Comput Biol"},{"key":"3988_CR42","first-page":"1","volume":"2015","author":"H Chen","year":"2015","unstructured":"Chen H, Zhang H, Zhang Z, Cao Y, Tang W. Network-based inference methods for drug repositioning. Comput Math Methods Med. 2015;2015:1\u20137.","journal-title":"Comput Math Methods Med"},{"key":"3988_CR43","unstructured":"Zhang P, Wang F, Hu J, Sorrentino R. Exploring the relationship between drug side-effects and therapeutic indications. In: American medical informatics association annual symposium proceedings; 2013. p. 1568\u20131577."},{"key":"3988_CR44","doi-asserted-by":"crossref","unstructured":"Li J, Lu Z. A new method for computational drug repositioning using drug pairwise similarity. In: IEEE international conference on bioinformatics and biomedicine: 2012-01-01 2012. United States: IEEE; 2012. p. 1\u20134.","DOI":"10.1109\/BIBM.2012.6392722"},{"issue":"D1","key":"3988_CR45","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47(D1):D1102\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3988_CR46","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3988_CR47","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2016","unstructured":"Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016;44(D1):D1075\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3988_CR48","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011;7(1):496.","journal-title":"Mol Syst Biol"},{"key":"3988_CR49","doi-asserted-by":"crossref","unstructured":"Wang B, Jiang J, Wang W, Zhou Z, Tu Z. Unsupervised metric fusion by cross diffusion. In: 2012 IEEE conference on computer vision and pattern recognition (CVPR) 2012-01-01 2012. IEEE; 2012. p. 2997\u20133004.","DOI":"10.1109\/CVPR.2012.6248029"},{"issue":"3","key":"3988_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nmeth.2810","volume":"11","author":"B Wang","year":"2014","unstructured":"Wang B, Mezlini AM, Demir F, Fiume M, Tu Z, Brudno M, Haibe-Kains B, Goldenberg A. Similarity network fusion for aggregating data types on a genomic scale. Nat Methods. 2014;11(3):333\u20137.","journal-title":"Nat Methods"},{"issue":"2","key":"3988_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2019","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4(2):293\u2013305.","journal-title":"Nat Microbiol"},{"key":"3988_CR52","doi-asserted-by":"crossref","unstructured":"Chen H, Guo R, Li G, Zhang W, Zhang Z. Comparative analysis of similarity measurements in miRNAs with applications to miRNA-disease association predictions. BMC Bioinform. 2020;21(1):176.","DOI":"10.1186\/s12859-020-3515-9"},{"key":"3988_CR53","doi-asserted-by":"crossref","unstructured":"Gloeckner CJ, Porras P. Guilt-by-association\u2014functional insights gained from studying the LRRK2 interactome. Front Neurosci Switz. 2020;14:485.","DOI":"10.3389\/fnins.2020.00485"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-03988-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-021-03988-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-03988-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:45:06Z","timestamp":1612824306000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-021-03988-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3988"],"URL":"https:\/\/doi.org\/10.1186\/s12859-021-03988-x","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}